Status:
TERMINATED
MEningioma Detection Using Non Contrast MRI TecHniquEs
Lead Sponsor:
Fondation Ophtalmologique Adolphe de Rothschild
Conditions:
Meningioma
Eligibility:
All Genders
18+ years
Brief Summary
Meningioma, an extra-axial brain tumor developed at the expense of meninges, accounts for 35% of central nervous system tumors, and its incidence is estimated at 3% in large autopsy series. The curre...
Eligibility Criteria
Inclusion
- Patient over 18 years of age
- Patient performing MRI as part of a screening or follow-up of known meningioma
- Express consent to participate in the study
Exclusion
- Contraindication for MRI (electrical device, metallic foreign body, claustrophobia)
- Known hypersensitivity to the contrast medium (Gadolinium)
- Known renal failure: glomerular filtration rate \<30mL/min
- Patient benefiting from a legal protection measure
- Pregnant or breastfeeding woman
Key Trial Info
Start Date :
June 12 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 2 2025
Estimated Enrollment :
315 Patients enrolled
Trial Details
Trial ID
NCT04113408
Start Date
June 12 2020
End Date
June 2 2025
Last Update
January 6 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondation ophtalmique Adolphe de Rothschild
Paris, Paris, France, 75019